conjugated goat anti-mouse I9M [Tago Inc.] for anti-NKHIA) for 40 min at 4°C. Cells were washed with PBS and then incubated with the third antibody (phycoerythrin [PE]-conjugated anti-CD4, OKT4-RDI; PE-conjugated anti-CD8, OKT8-RDI ; Ortho Diagnostic Systems, Raritan, NJ; PE-conjugated-anti-4114, Coulter Immunology, Hialeah, FL) . After washing with PBS, cells were resuspended in PBS or 1.0% formalin-PBS (cells from infected individuals were resuspended in 1 .0% formalin-PBS and left overnight to inactivate virus) . Flow cytometric analyses were performed on an EPICS-CS (Coulter Electronics, Hialeah, FL) . Cells were also first reacted with an irrelevant antibody to demonstrate the specificity of the staining shown with the other antibodies.
RT Assay. RT assays were performed as previously described (10) . One-Dimensional Isoelectric Focusing (1-D IEF)Analysis ofMHC Class I Glycoproteins . 1-D IEF studies were performed on lectin-activated PBL of rhesus monkeys as previously described (15, 16) . In brief, PBL were biosynthetically labeled with ["S]methionine and lysed. Lysates were phase separated, precleared, and MHC class I molecules were immunoprecipitated with the mAb BB7 .7 (17) . Neuraminidase-treated samples were subjected to 1-D IEF; the pH gradient across the gel was approximately pH 5-7 .
Results
CD8+ Lymphocytes Inhibit SIV ., Replication in PBL of Infected Monkeys. We first sought to define the cell population in PBL of SIVmac-infected rhesus monkeys which inhibits SIVnac replication . As shown in Fig . 1 , Con A-activated PBL of SIVnac -infected, clinically healthy monkeys maintained in culture in the presence of IL-2 do not generate RT activity. This indicates that virus replication is not occurring. However, after depletion of CD8 + cells from those lymphocytes, viral replication is easily demonstrated . The addition of autologous CD8' cells to these CD8+ lymphocyte-depleted PBL inhibits this virus replication. Thus, as described for HIV-1 by Walker et al. (6) , SIVmac replication in PBL of rhesus monkeys is inhibited by autologous CD8 + lymphocytes.
In Vitro AIDS Virus Replication in PBL ofInfected Humans or Monkeys Is Perpetuated by Cell-to-Cell Spread of Virus. Virus replication in such CD8+ lymphocyte-depleted PBL could result either from uninhibited replication in a large number of previously infected cells or an infection spreading to previously uninfected cells from a limited number of cells . Since anti-CD4 antibody should block the spread of infectious virus from one cell to another, inhibition of replication by addition of anti- Autologous CD8' lymphocytes inhibit the generation of RT activity in vitro in CD8' lymphocyte-depleted PBL from SIVmac-infected rhesus monkeys . After Con A activation, PBL were left unfractionated (O) or CD8' lymphocytes were depleted by the technique of panning(*) and cells were then maintained in IL-2-supplemented culture medium. . 5 x 105 autologous CD8' lymphocytes were added back (A) to 5 x 105 CD8' lymphocyte-depleted cells in a 2-ml volume. RT activity was regularly assessed in the culture medium as a measure of virus replication.
CD4 would indicate that infection is propagated under these culture conditions by spread from infected cells to uninfected cells. CD8' lymphocyte-depleted PBL from an SIVnac-infected monkey were Con A activated and then maintained in IL-2-supplemented medium in the absence of mAbs or in the continuous presence of an irrelevant mAb, an anti-CD4 mAb or with the anti-CD4 mAb added on day 3 or day 10 of culture ( Fig . 2 A) . While SIVmac replication occurred in the absence of mAb and in the presence of an irrelevant mAb, all detectable replication was inhibited when anti-CD4 antibody was added on day 3 of culture. Moreover, ongoing replication was blocked by the addition of anti-CD4 mAb to the cells on day 10 of culture. Similar results were seen in parallel studies of CD8' lymphocyte-depleted PBL of HIV-1-infected humans (Fig . 2 B) . Not only did the addition of an anti-CD4 mAb on day 12 of culture block ongoing HIV-1 replication, but the removal of the anti-CD4 mAb on day 8 from the cultures continuously exposed to anti-CD4 antibody resulted in a delayed initiation of detectable HIV-1 replication in these PBL. Thus, in vitro replication of both SIV.ac and HIV-1 in CD8' lymphocyte-depleted PBL of infected individuals appears to reflect spread of infectious virus from a limited number of cells to the other IL-2-driven lymphocytes. The CD8' lymphocyte may, therefore, be capable of inhibiting the cell-to-cell spread of infectious virus. CD8' Inhibitory Lymphocytes Are Detectable only Weeks after SIV. Infection . We initially sought to determine whether the CD8`cells that inhibit AIDS virus replication in PBL of infected individuals have characteristics of antigen-specific lymphocytes. Detection ofthese cells in PBL of rhesus monkeys immediately after infection with SIVmac would be consistent with their being NK cells. Their detection in monkey PBL only after a period of weeks after virus infection would suggest that they may undergo clonal expansion and might, therefore, be antigen specific. Four normal rhesus monkeys were experimentally inoculated with SIVmac and their CD8' PBL were assessed for inhibition of SIVmac replication. Such an inhibitory cell population was not detectable in PBL ofany ofthe four animals 1 wk after infection (data not shown). As summarized in Table I , this CD8' cell population was detectable in one of the four animals at 13 d after infection, in three of the four animals at 30 d after infection and in all of the animals 60 and 90 d after infection . This observation suggests that a clonal expansion of the CD8' cell population capable of inhibiting viral replication may occur in the initial weeks after infection . Thus, these CD8' cells may be antigen specific rather than an NK cell population .
The CD8' Lymphocyte That Inhibits AIDS Virus Replication Is not a NK Cell. The possibility that the cell that inhibits AIDS virus replication in vitro might be a NK cell was then investigated . Virus replication was assessed in NK cell-depleted PBL from SIVmac -infected, clinically healthy rhesus monkeys . These PBL were treated with anti-CD8, anti-NKH1, or anti-CD16 and complement and then maintained in IL-2-supplemented medium. As shown in Table II , SIVmac replication was demonstrated in CD8' lymphocyte-depleted, but not in NKH1' or CD16' lymphocyte-depleted PBL . Similar results were observed in parallel studies of PBL from HIV-1-infected humans (Table III) . These studies suggest that the CD8' cell that inhibits SIVmac and HIV-1 replication in vitro does not express NK cell-associated surface antigens. monkey are MHC class I restricted . Because MHC typing sera for rhesus monkeys are not widely available and are incomplete in the spectrum ofspecificities they define, we used 1-D IEF to characterize the MHC class I phenotype of clinically healthy SIVmac-infected rhesus monkeys. As shown in Fig. 3 A, studies of this type yield a distinct banding pattern on a 1-D IEF gel for each animal, every band representing a different MHC class I allelic product. Although MHC class I-matched, unrelated SIVmac-infected monkeys were not available for study, MHC class I-disparate infected animals could be readily defined. Animals 51, 249, and 434 differed in their expression of MHC class I alleles. Con A-activated CD8' lymphocyte-depleted PBL from rhesus monkey 434 were maintained in culture in the presence of IL-2.
As shown in Fig. 3 B, virus replication occurred in the absence of reconstitution with CD8' lymphocytes, and was inhibited with the addition of autologous CD8' cells. The addition of MHC class I-mismatched populations of CD8' cells from SIVmac-infected animals 249 or 51 failed to inhibit virus replication. These mismatched CD8' cell populations inhibited SIVmac replication in autologous CD8+ lymphocyte-depleted PBL (data not shown) . Therefore, MHC class I-mismatched CD8' cells do not inhibit the in vitro replication of SIVmac under these culture conditions. The AIDS Virus Inhibitory Cells Are a Phenotypically Distinct Subpopulation of CD8+ PBL. We further characterized the CD8' cell that inhibits SIVmac and HIV-1 replication by determining whether the virus inhibitory activity resides in all CD8`cells or in a subpopulation of phenotypically distinct CD8' cells. In pursuing these studies, we made use ofthe observation that recently defined surface antigens are expressed on functionally distinct subpopulations of human and rhesus monkey CD8' lymphocytes . The antigens assessed in these studies included 2H4, 4B4, and S6F1 . 2H4 is a member of the T200 family of molecules (18), 4B4 is a member of the integrin family of cell surface molecules (19) , and S6F1 is an epitope of the cell adhesion molecule LFA-1 (20) . As shown in Figure 4 A, human CD8' PBL (and rhesus monkey CD8+ PBL; data not shown) can be fractionated into mutually exclusive 4B4+2H4-and 4B4-2H4' subpopulations . Moreover, as shown in Fig. 4 B, the CD8+4B4+ human lymphocytes also express S6F1 .
CD8+ lymphocytes were prepared from PBL of an HIV-1-infected, clinically healthy human and fractionated by the panning method into 2H4+ and 2H4-subpopulations. These subpopulations of CD8' cells were then added to CD8+ lymphocyte-depleted autologous PBL and RT activity in the supernatants of these reconstituted cultures was monitored. As shown in Fig. 5 B, the unfractionated CD8' lymphocytes significantly inhibited RT activity in autologous CD8' lymphocyte-depleted PBL. While the 4B4-S6F1 -2H4+ subpopulation of CD8+ lymphocytes had no HIV-1 inhibitory activity, the 4B4+S6F1 + 2H4 -subpopulation totally inhibited HIV-1 replication in vitro. An analogous experiment was done using similarly prepared subpopulations of CD8' lymphocytes from SIVIpac-infected, clinically healthy rhesus monkeys. As shown in Fig. 5 A, virtually no inhibitory activity was observed in the CD8' cell subpopulation that was 4B4 -2H4* . However, complete inhibition of RT activity was seen in cultures reconstituted with CD8+ 4B4+ 2H4-cells. Thus, both in PBL of HIV-1-infected humans and SIVnac-infected rhesus monkeys, viral replication was inhibited by a subpopulation of CD8' lymphocytes.
Since 4B4 is a member of the integrin family of molecules, molecules involved in cell adhesion, these findings suggested that cell contact might occur between the virus inhibitory cell and the cell harboring viral replication . Moreover, S6F1 has recently been shown to be expressed by CD8* cytotoxic effector but not CD8* suppressor effector lymphocytes (19) . This phenotypic characterization of the CD8* lymphocytes that inhibit AIDS virus replication in vitro suggested that the cell that inhibits viral replication may, in fact, be a CTL that must come into direct physical contact with its target cells in vitro.
Cell-to-Cell Contact Is Requiredfor CD8' Lymphocyte-mediated Inhibition ofAIDS Virus Replication. We then examined the cell interactions leading to the inhibition of viral replication, assessing the possible importance of cell contact in these interactions . Anti-LFA-1 antibodies have been shown to inhibit killer effector-target adhesion (21) . Lectin-activated PBL from a clinically healthy HIV-1-infected human were placed in culture in IL-2-supplemented medium in the presence of two irrelevant mAbs or in the presence of an anti-LFA-la mAb (Fig. 6 ) . While no virus replication was seen in the absence of a mAb or in the presence of irrelevant mAbs, viral replication was readily demonstrated in the culture maintained in the presence of the antiLFA-1ct mAb. (These studies were not done on PBL from SIVnnac -infected monkeys because this anti-LFA-1a mAb does not react with rhesus monkey cells.) This finding suggested that direct cell contact is required between the CD8* lymphocyte and its target cell in vitro for inhibition of viral replication to occur.
We further characterized the lymphocyte that inhibits SIVmac replication by examining the role of the CD8 molecule in this inhibitory process. Anti-CD8 mAbs have been shown to block the effector function of both allo-specific and virus-specific CTL (2, 22) . If the CD8 molecule were specifically involved in the inhibition of virus replication, mAbs directed against critical epitopes of the CD8 structure might be expected to inhibit the ability of the CD8* lymphocytes to subserve their inhibi- tory function . As shown in Fig. 7 A, while Con A-activated unfractionated PBL from SIVac-infected monkeys did not generate significant RT activity when maintained in culture with an irrelevant or an anti-CD2 mAb, virus replication occurred if these cultured PBL were maintained in the presence of an anti-CD8 mAb. Thus, the addition of certain anti-CD8 mAbs to PBL from SIVma,-infected monkeys in vitro blocked the inhibitory function of the CD8+ lymphocytes.
We then sought to determine the relevance of this observation for the control of HIV-1 replication in human PBL. As previously shown in the SIVma, system, virus replication was not detected in Con A-activated PBL of clinically healthy, HIV-1-infected humans. HIV-1 replication was, however, detected after CD8+ lymphocyte depletion (data not shown) . Importantly, when the function of the CD8 molecule was blocked by certain anti-CD8 mAbs, these CD8+ T lymphocytes were no longer capable of inhibiting virus replication (Fig. 7 B) . Thus, the CD8 molecule appears to play a crucial role in the cell-cell interactions that result in the inhibition of both SIVma, and HIV-1 replication in vitro.
Discussion
These studies characterize a PBL population from AIDS virus-infected individuals capable of inhibiting AIDS virus replication. These cells were shown to be CD8', undergo clonal expansion in vivo after AIDS virus infection of the individual, and block replication of virus in autologous but not MHC class I-mismatched PBL. These cells express membrane structures that are involved in cell adhesion and their ability to inhibit virus replication can be blocked with mAbs that interfere with physical contact between the CD8+ lymphocytes and their target cells.
Several lines of evidence establish that the AIDS virus inhibitory CD8' lymphocyte in PBL of infected individuals is not a NK cell . Depletion from PBL of cells expressing the NK-associated antigens NKH1 and CD16 did not facilitate virus replication in cultures . The inhibition of AIDS virus replication was also blocked by anti-CD8 mAbs. In other experimental systems, anti-CD8 mAbs, while inhibiting CTL effector function, do not inhibit NK activity (2, 23) . Finally, in the current studies, the CD8' lymphocyte-depleted cells that support virus replication, even at the time of peak AIDS virus replication, contain a substantial number of NKH1' cells (data not shown) .
Since these virus inhibitory CD8' lymphocytes are not NK cells, they are likely to be antigen specific. We have previously shown that CD8' cells capable of inhibiting AIDS virus replication are present in PBL of infected but not uninfected individuals (14) . We have now demonstrated that a period of weeks is required after infection for a maturation of the CD8' lymphocyte-mediated inhibitory response . We also have previously shown that cell lines that exhibit this inhibitory function can be established in vitro by stimulating PBL from SIVmacinfected monkeys with autologous SIV ..a, antigen-expressing cells in the presence of IL-2 (14) . It will, however, be necessary to show that the CD8' cells that inhibit virus replication can be generated by specific antigen priming or that such cells isolated from infected individuals have specific proliferative activity after AIDS virus antigen stimulation to establish conclusively that they are indeed antigen specific.
Antigen-specific CD8' lymphocytes should be MHC class I restricted in their cell-cell interactions . We were able to demonstrate that CD8' lymphocytes were incapable of inhibiting viral replication in PBL of MHC class I-mismatched SIVma,-infected monkeys. However, MHC class I-matched unrelated SIVrt,acinfected monkeys were not available for study. Thus, we could not formally prove that MHC class I matching between the CD8' cell population and the CD8' lymphocyte-depleted PBL was sufficient to facilitate an inhibitory interaction. However, these findings are consistent with our previous observation that a long-term T lymphocyte line, generated from rhesus monkey PBL by repeated in vitro stimulation with autologous SIVa,-infected cells in the presence of IL-2, inhibited SIVma, replication in CD8' lymphocyte-depleted autologous lymphocytes, but not in CD8' lymphocyte-depleted cells from a MHC class I-mismatched animal (14) . These experiments together demonstrate, within the limitations ofour experimental systems, that the interactions of this CD8' lymphocyte population may be MHC class I restricted .
Thus, these studies provide evidence that the CD8' inhibitory cells may be antigen specific and MHC class I restricted . These findings, coupled with the observation that the inhibitory cells are S6F1+ and the demonstration that this inhibitory function can be blocked both with anti-LFA-1 and anti-CD8 mAbs, provide compelling evidence that this CD8' cell is, in fact, a CTL.
The observation that the inhibitory CD8' cell is phenotypically a CTL makes the studies with the mAbs anti-2114 and anti-4134 particularly interesting. While previous work with these mAbs indicates that CD4' cells can be divided into phenotypically and functionally distinct groups that subserve either helper function or inducer of suppression function (24, 25) , little work has been done with these antibodies in the study of CD8' lymphocytes. The current experiments suggest that functional virus-specific cytotoxic cells may be contained only within the 4B4'2H4 -subpopulation of CD8' lymphocytes.
While these studies indicate that the cell which inhibits HIV-1 and SIV,nac replication in PBL is phenotypically a CTL, the mechanism by which this CD8' lymphocyte inhibits the replication of virus remains to be elucidated. Cell contact is required between the CD8' lymphocyte and cells harboring replicating virus since this inhibitory process can be blocked by anti-LFA-1 and anti-CD8 mAbs. It is not clear, however, whether this cell contact is necessary only for the triggering of factor secretion by these CD8' cells, which in turn inhibits virus replication, or whether this CD8' cell, in fact, lyses the AIDS virus-expressing target cell . It is interesting to speculate that this AIDS virus-inhibiting cell might represent the same subset of lymphocytes in PBL capable of lysing autologous AIDS virus-expressing target cells (3) (4) (5) . Summary CD8' (suppressor/cytotoxic) lymphocytes block replication of HIV-1 or the simian immunodeficiency virus of macaques (SIVma~) in PBL of infected individuals. We now show that these CD8' lymphocytes undergo clonal expansion in vivo after AIDS virus infection of the individual, suggesting they may be antigen-specific T cells. These CD8' cells block replication of virus in autologous but not MHC class I-mismatched PBL. The inhibitory lymphocytes express the integrin family molecule 4B4 and the CTL-associated S6F1 epitope of LFA-1. Finally, physical contact is required for the CD8' lymphocyte-mediated inhibition of AIDS virus repli-cation, since this inhibitory function is blocked by anti-LFA-1 and anti-CD8 rnAbs. These studies suggest that the cell that inhibits AIDS virus replication in PBL of infected individuals is a CTL .
